Results 131 to 140 of about 10,701 (213)

Safety and Efficacy of Natural and Conventional Psychiatric Treatments: A Comparative Review of Mushroom-Derived Compounds and Medicinal Plants in the Management of Mental Disorders. [PDF]

Molecules
Gawłowska K, Nowakowska KK, Makówka JW, Bajurny W, Góral MP, Bocheńska A, Kopecki SD, Grodzińska WM, Chłopaś-Konowałek A.   +8 more
europepmc   +1 more source

Psilocybin produces amplified acute responses and sex-specific long-term increases in sensorimotor gating in the mGlu5 knockout mouse model of schizophrenia. [PDF]

Neuropsychopharmacology
Gattuso JJ, Kamal A, Payet JM, Havaux K, Hendey J, Bezcioglu B, Phelan ZJ, Orchard M, Bhanot D, Hale MW, Hannan AJ, Renoir T.   +11 more
europepmc   +1 more source

Implications of Potential US FDA Approval of Psychedelics or Psychedelic-Adjacents Such as Ibogaine for Pharmacy in Japan. [PDF]

Cureus
Raffa RB.
europepmc   +1 more source

Psilocybine Measurement [PDF]

, 2020
openaire   +1 more source

Psilocybin-containing mushroom-assisted psychotherapy is associated with sustained psychological and somatic improvements: two case studies from Jamaica. [PDF]

Front Psychiatry
Sams CH, Davis J, Ramdas A, Delgoda R, Vidot D, Reid M, De La Haye W.   +6 more
europepmc   +1 more source

The mechanism debate in psilocybin therapy for depression. [PDF]

EBioMedicine
eBioMedicine.
europepmc   +1 more source

Psychedelic integration beyond the verbal: participatory-imaginal processing as a hypothesis-generating therapeutic framework. [PDF]

Front Psychiatry
Back AL, Bosnak R.
europepmc   +1 more source

Safety and Mental Health Outcomes of Oregon State-Regulated Psilocybin Services.

JAMA Netw Open
Korthuis PT, Cook RR, Gregoire D, Stauffer CS, Luoma JB, Pertl K, Des Jarlais D, McCarty D, Levander XA, Hoffman KA, Wilson-Poe AR.   +10 more
europepmc   +1 more source

Psychedelic Safety and Clinical Outcomes Across Exposure Patterns: A Structured Narrative Review. [PDF]

Life (Basel)
Kéri S.
europepmc   +1 more source

Longitudinal neural and psychological changes following psilocybin under compassion imagery priming. [PDF]

Front Hum Neurosci
Pallavicini C, Llobenes L, Cavanna F, de la Fuente LA, Muller S, Costa M, Gumiy N, Bruno N, D'Amelio T, Basran J, Plowright P, Zamberlan F, Pasqualetti G, Stolkiner A, Namías M, Gilbert P, Tagliazucchi E.   +16 more
europepmc   +1 more source